Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 26, 1492-1496, July 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boot, L. M.
Right arrow Articles by Röpcke, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boot, L. M.
Right arrow Articles by Röpcke, G.

Studies on Hypophyseal Isografts in Mice1

I. Biologic Aspects

L. M. Boot and G. Röpcke

Biological Department, Antoni van Leeuwenhoekhuis, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Experiments are reported on the induction of mammary carcinoma in intact, mammary tumor agent (MTA)-free female (female O20 x male DBAf)F1 mice by single and multiple (4) prolactin-producing hypophyseal isografts in the kidney. Tumor incidences varying between 67 and 88% were recorded in the treated groups as against 2% in virgin controls. Identical treatment of intact and castrated males proved totally ineffective. In the female hosts all grafts became extremely enlarged—some weighing up to 2000 mg or even more—whereas in the male animals they seldom exceeded 10 mg. Evidence is put forward which suggests a difference in hypothalamic control over the ectopic hypophyses between female and male animals due to a basic difference in hypothalamic prolactin-inhibiting factor (PIF) potency, which is enhanced by the suppression of PIF by estrogens. The neoplastic transformation of the enlarged grafts is questioned.

1 This investigation has been supported by a research grant, C-3431, from the National Cancer Institute, USPHS.

Received 10/ 4/65. Revised 1/17/66.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1966 by the American Association for Cancer Research.